Mednax is trading 4.3% lower at $28.27, compared with its October 22 close of $29.55. - The provided market backdrop is mildly negative but does not show a sufficiently large same-direction move to establish a broad-market explanation. - No clear company-specific catalyst for the pre-market drop surfaced in the available coverage. - Mednax’s third-quarter results call is scheduled for October 29, making it upcoming rather than a reported earnings trigger for October 23.